GlassScriptPhysician profile
Joseph Kofi Amoah
NPI 1093398877
$606.83
in general payments reported to CMS, 2019-2025
9 companies · $311 in 2025
The $311 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $296 · 2025: $311.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $327 · Education: $279.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $327.34 |
| Education | $279.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $279.49 | 2025 | Ensite |
| Medtronic, INC. | $151.64 | 2024 | Corevalve Evolut R |
| Ucb, INC. | $39.05 | 2024 | Cimzia |
| Lantheus Medical Imaging, INC. | $38.32 | 2024-2025 | |
| Amgen INC. | $35.49 | 2024 | Repatha |
| Aurinia Pharma U.S., INC. | $17.48 | 2024 | Lupkynis |
| E.R. Squibb & Sons, L.L.C. | $16.32 | 2024 | Eliquis |
| Alnylam Pharmaceuticals INC. | $16.06 | 2024 | Onpattro |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $12.98 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Amoah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.